首页> 外文期刊>European Heart Journal: The Journal of the European Society of Cardiology >The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability
【24h】

The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability

机译:稳定心绞痛患者的规划和排列大型冠状动脉狭窄的非侵入性试验的性能:荟萃分析,重点是测试后疾病概率

获取原文
获取原文并翻译 | 示例
           

摘要

Aims To determine the ranges of pre-test probability (PIP) of coronary artery disease (CAD) in which stress electrocardiogram (ECG), stress echocardiography, coronary computed tomography angiography (CCTA), single-photon emission computed tomography (SPECT), positron emission tomography (PET), and cardiac magnetic resonance (CMR) can reclassify patients into a post-test probability that defines (85%) or excludes (15%) anatomically (defined by visual evaluation of invasive coronary angiography [ICA]) and functionally (defined by a fractional flow reserve [FFR] = 0.8) significant CAD.
机译:旨在确定冠状动脉疾病(CAD)的测试前概率(PIP)的范围,其中应力心电图(ECG),应力超声心动图,冠状动脉计算机断层造影血管造影(CCTA),单光子发射计算断层摄影(SPECT),正电子 发射断层扫描(PET)和心脏磁共振(CMR)可以将患者重新分类为测试后概率,该概率分解(& 85%)或不包括(& 15%)解剖学上(通过侵入性冠状动脉造影的视觉评估定义[ICA) ])和在功能上(由分数流量储备[FFR]限定[FFR]& = 0.8)有效的CAD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号